Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Takeda Pharmaceutical
TAK
$55.5B
| $371K | ﹤0.01% |
23,975
+6,038
| +34% | +$89.2K |
|
3652
Microvast
MVST
$341M
| $367K | ﹤0.01% |
101,233
+77,391
| +325% | +$226K |
|
3653
Mineralys Therapeutics
MLYS
$2.31B
| $367K | ﹤0.01% |
27,118
+6,125
| +29% | +$88.8K |
|
3654
Yext
YEXT
$613M
| $367K | ﹤0.01% |
43,160
-38,608
| -47% | -$271K |
|
3655
Vinci Compass Investments Ltd
VINP
$623M
| $367K | ﹤0.01% |
37,937
+27,908
| +278% | +$269K |
|
|
CBL
3656
CBL Properties
CBL
$1.78B
| $367K | ﹤0.01% |
14,446
-9,504
| -40% | -$234K |
|
3657
Replimune Group
REPL
$1.42B
| $366K | ﹤0.01% |
39,435
-76,034
| -66% | -$663K |
|
3658
Adtran
ADTN
$658M
| $366K | ﹤0.01% |
40,835
-115,784
| -74% | -$924K |
|
3659
Liberty Latin America Class C
LILAK
$1.65B
| $366K | ﹤0.01% |
64,709
-53,883
| -45% | -$264K |
|
|
SPNS
3660
DELISTED
Sapiens International
SPNS
| $365K | ﹤0.01% |
12,493
-10,817
| -46% | -$301K |
|
|
NPKI
3661
NPK International
NPKI
$1.18B
| $365K | ﹤0.01% |
42,843
-28,707
| -40% | -$210K |
|
3662
MiMedx Group
MDXG
$612M
| $364K | ﹤0.01% |
59,642
-79,416
| -57% | -$528K |
|
3663
Enliven Therapeutics
ELVN
$4.25B
| $364K | ﹤0.01% |
18,139
-12,700
| -41% | -$240K |
|
3664
Rocket Pharmaceuticals
RCKT
$367M
| $363K | ﹤0.01% |
148,029
-86,149
| -37% | -$436K |
|
3665
Xeris Biopharma Holdings
XERS
$1.52B
| $362K | ﹤0.01% |
77,534
-40,674
| -34% | -$186K |
|
|
AVDL
3666
DELISTED
Avadel Pharmaceuticals
AVDL
| $360K | ﹤0.01% |
40,637
-33,135
| -45% | -$291K |
|
3667
Utz Brands
UTZ
$1.25B
| $359K | ﹤0.01% |
28,643
-47,884
| -63% | -$626K |
|
3668
FLEX LNG
FLNG
$1.64B
| $359K | ﹤0.01% |
16,175
-10,860
| -40% | -$255K |
|
3669
Kearny Financial
KRNY
$604M
| $357K | ﹤0.01% |
55,263
-14,907
| -21% | -$91.9K |
|
3670
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.1B
| $357K | ﹤0.01% |
12,211
-7,902
| -39% | -$227K |
|
3671
Clarivate
CLVT
$1.25B
| $357K | ﹤0.01% |
82,913
+58,744
| +243% | +$237K |
|
|
GES
3672
DELISTED
Guess Inc
GES
| $356K | ﹤0.01% |
29,482
-3,294
| -10% | -$36.8K |
|
3673
Barings BDC
BBDC
$987M
| $356K | ﹤0.01% |
38,908
+27,154
| +231% | +$241K |
|
3674
Lifestance Health
LFST
$4.67B
| $355K | ﹤0.01% |
68,743
-39,946
| -37% | -$239K |
|
3675
PennantPark Floating Rate Capital
PFLT
$752M
| $355K | ﹤0.01% |
34,398
+23,600
| +219% | +$239K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.